Trimethobenzamide trade names Tebamide Tigan is an antiemetic used to prevent nausea and vomiting
Trimethobenzamide is an antagonist of the D receptor
It is believed to affect the chemoreceptor trigger zone CTZ of the medulla oblongata to suppress nausea and vomiting
Possible side effects include drowsiness dizziness headache muscle cramps and blurred vision
More serious adverse effects include skin rash tremors parkinsonism and jaundice
Trimethobenzamide is marketed under the brand names Tebamide and Tigan manufactured by GlaxoSmithKline and King Pharmaceuticals respectively
It is available as oral capsules and injectable formulations
Trimethobenzamide was also available as a rectal suppository but such formulations were banned by the US
Food and Drug Administration on April due to unproven efficacy
Alkylation of the sodium salt of p-hydroxybenzaldehyde with -dimethylaminoethyl chloride affords the ether
Reductive amination of the aldehyde in the presence of ammonia gives diamine
Acylation of that product with -trimethoxybenzoyl chloride affords trimethobenzamide